Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|36|1|363-365

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 363-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Hematopoietic Stem Cell Transplantation in Multiple Myeloma

By Harousseau Jean-Luc  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 9, 2009-10 ,pp. : 961-970

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Carfilzomib: In Relapsed, or Relapsed and Refractory, Multiple Myeloma

By McCormack Paul L.  

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 2023-2032

Adis International

Access to resources Recommend Favorite

High-dose tamoxifen is not a feasible option in patients with relapsed or refractory multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients

By Barbee Meagan S.   Nooka Ajay   Kaufman Jonathan L.   Kim Sungjin   Chen Zhengjia   Heffner Leonard T.   Lonial Sagar   Harvey R. Donald  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 853-862

Blackwell Publishing

Access to resources Recommend Favorite

The Role of Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Myeloma

By Bensinger William I.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 4, 2004-07 ,pp. : 371-378

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite